MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra...
Vous n'êtes pas connecté
KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake.
MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra...
SNY posts strong third-quarter results, beating estimates for both earnings and sales. Shares rise in pre-market.
Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales. Management raises...
ROCK's third-quarter results reflect solid gains from Agtech amid lower contributions from the Residential and Renewables segments.
UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.
QGEN delivers another solid performance in the third quarter of 2024, with both the top and bottom lines surpassing estimates.
FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.
BMY posts impressive third-quarter results, with both earnings and sales beating the respective estimates. The company also raises its annual earnings...